Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 1.900
+0.100 (5.56%)
Jul 27, 2026, 5:15 PM GMT
Proteome Sciences Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7 | 7 | 10 | 13 | 10 | 15 | |
Market Cap Growth | -25.74% | -26.47% | -24.95% | 29.43% | -31.71% | 32.43% |
Enterprise Value | 21.65 | 22.37 | 23.43 | 24.82 | 18.25 | 24.43 |
Last Close Price | 0.02 | 0.03 | 0.03 | 0.05 | 0.04 | 0.05 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 8.14 | 256.25 |
Forward PE | - | 86.11 | 86.11 | 86.11 | 86.11 | 86.11 |
PS Ratio | 1.77 | 1.96 | 2.05 | 2.66 | 1.33 | 2.95 |
PB Ratio | -0.70 | -0.77 | -1.54 | -4.36 | -12.26 | -5.45 |
P/FCF Ratio | - | - | - | - | 5.67 | 25.68 |
P/OCF Ratio | - | - | - | - | 4.83 | 19.08 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.76 | 5.96 | 4.79 | 4.94 | 2.35 | 4.76 |
EV/EBITDA Ratio | - | - | - | - | 9.07 | 39.08 |
EV/EBIT Ratio | - | - | - | - | 10.56 | 59.29 |
EV/FCF Ratio | - | - | - | - | 10.02 | 41.47 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -1.60 | -1.60 | -2.14 | -4.20 | -13.78 | -4.12 |
Debt / EBITDA Ratio | - | - | - | - | 5.92 | 18.70 |
Debt / FCF Ratio | - | - | - | - | 6.54 | 19.84 |
Net Debt / Equity Ratio | -1.57 | -1.57 | -2.06 | -3.73 | -9.40 | -3.35 |
Net Debt / EBITDA Ratio | -11.30 | -8.61 | -8.84 | -10.07 | 3.94 | 14.88 |
Net Debt / FCF Ratio | -104.82 | -104.82 | -12.76 | -15.94 | 4.35 | 15.79 |
Asset Turnover | 0.43 | 0.43 | 0.47 | 0.42 | 0.69 | 0.54 |
Inventory Turnover | 6.05 | 6.05 | 5.38 | 3.89 | 3.03 | 2.21 |
Quick Ratio | 0.09 | 0.09 | 0.13 | 0.27 | 0.48 | 0.30 |
Current Ratio | 0.13 | 0.13 | 0.18 | 0.33 | 0.55 | 0.39 |
Return on Equity (ROE) | 51.36% | 51.36% | 64.48% | 122.44% | -65.51% | -5.35% |
Return on Assets (ROA) | -35.04% | -35.04% | -21.66% | -13.43% | 14.52% | 5.98% |
Return on Capital Employed (ROCE) | 40.64% | 40.64% | 80.85% | 302.43% | -199.77% | -19.71% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | - | - | - | - | 12.29% | 0.39% |
FCF Yield | - | - | - | - | 17.63% | 3.89% |
Buyback Yield / Dilution | 0.81% | 0.81% | 1.25% | -0.71% | -2.38% | -2.26% |
Total Shareholder Return | 0.81% | 0.81% | 1.25% | -0.71% | -2.38% | -2.26% |